[Summary] Leader in providing mass spectrometry system solutions
Shanghai Zhongke New Life Biotechnology Co., Ltd. (APTBIO) was established in 2004, formerly the external service platform of the Proteomics Research and Analysis Center of the former Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. Through technical cooperation with domestic and international research institutions and the innovative capabilities of its own R&D team, the company established an innovative research institute, building four major technology platforms: large-cohort multi-omics research technology platform, biopharmaceutical early research and preclinical CMC research and analysis platform, biopharmaceutical and medical device registration and approval platform, and AI big data algorithm platform. It lays out two business segments: technology services and biopharmaceutical and consumer healthcare CRO services, constructing a life sciences and health business landscape that combines AI big data with mass spectrometry-based multi-omics technology application.
The company is headquartered in Shanghai, with data centers, innovation technology centers, and GMP factories built in Yiwu and Shanghai. The laboratory and office area exceeds 15,000 square meters. Currently, Zhongke New Life has three wholly-owned subsidiaries, with marketing centers in Beijing, Guangzhou, Tianjin, Chongqing, and other cities, establishing a nationwide marketing network. The company has built a team of high-quality comprehensive talents, including Ph.D.s from domestic and international institutions and interdisciplinary experts, with over 65% of employees holding a master's degree or above. As of the end of 2022, Zhongke New Life has served over 30,000 projects cumulatively, co-published over 1,700 SCI articles with project partners, with an accumulated impact factor exceeding 10,000 points. The company has obtained more than 50 invention patents, utility model patents, and computer software copyrights. Partnerships include over 1,500 research institutes and universities, over 1,000 hospitals, and over 2,000 well-known biomedical companies, establishing a leading position in the fields of technology services, biomedical CRO, and healthcare consumer testing services.
As an innovative technology service company, Zhongke New Life deeply understands customer needs, takes comprehensive innovation as its core value, adheres to the core values of "Innovation First, Integrity First, Pragmatism First," is committed to becoming a life science technology service provider driven by mass spectrometry multi-omics, continues to break through in frontier technology R&D cooperation and transformation, and innovatively leads the new landscape of life sciences and health.
What does Shanghai Zhongke New Life Biotechnology Co., Ltd. require? Who is Zhongke New Life hiring? Zhongke New Life recruitment: 科研类占比最多占48%，其次是销售类占42.2%. What education can get in at Zhongke New Life? 硕士占比最多占67.3%，其次是本科占22.9%. High education required at Zhongke New Life? 硕士占67.3%，博士占1.6%. Work experience required at Zhongke New Life? 不限占比最多占58.3%，其次是1-3年占20.4%. Where are the job locations at Zhongke New Life? 上海占比最多占58.3%，其次是金华占6.5%. Based on job postings from the past year, for reference only.
Provided by
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows
Jobui does not provide an APP. Please follow our WeChat official account.
